김종민 (숙명여자대학교)님 | 한빛사연구자 > 한빛사

숙명여자대학교

최종업데이트 2025.12.13.

Dihydroartemisinin inhibits metastatic potential and cancer stemness by modulating the miR-200b-BMI-1/VEGF-A axis in ovarian cancer
- Exp. Mol. Med., Dec 05 2025, | https://doi.org/10.1038/s12276-025-01582-2
- 2025-12
- 의약학
- 한빛사논문
Novel biomarker discovery-coupled plasma therapy with enhanced tumor penetration for non-surgical treatment of cervical cancer
- J. Control. Release, Jun 10 2025, S0168-3659(25)00566-8 | https://doi.org/10.1016/j.jconrel.2025.113946
- 2025-06
- 바이오·의료융합
- 한빛사논문
MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer
- Mol. Ther.-Nucl. Acids, Available online 24 August 2022 | https://doi.org/10.1016/j.omtn.2022.08.028
- 2022-08
- 의약학
- 한빛사논문
MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation
- Nat. Commun., Published 12 April 2016, 7, Article number: 11268 2016, doi:10.1038/ncomms11268
- 2016-04
- 생명과학
- 한빛사논문
Restoration of Impaired Endothelial MEF2 Function Rescues Pulmonary Arterial Hypertension
- Circulation, October 21, 2014 | doi: 10.1161/CIRCULATIONAHA.114.013339
- 2014-10
- 생명과학
- 한빛사논문
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension
- Nat. Med., Published online 23 December 2012 | doi:10.1038/nm.3040
- 2012-12
- 생명과학
- 한빛사논문

연구자 ID

저자논문